Demand is shifting to rapid, decentralized and at-home molecular testing, creating opportunities in consumables, multiplex panels, portable PCR, CRISPR diagnostics and Asia-Pacific expansion.Dublin, ...
Helix, the leading enterprise genomics platform, today announced the availability of Whole Exome+® Sequencing (WES+), a comprehensive diagnostic sequencing test now available to ordering providers ...
The foundations of brain development are laid during a crucial period of pregnancy, and a common household plasticizer called ...
The following biotech stocks reached a 52-week high on September 16, 2026, driven by positive results from clinical trials or an upcoming conference participation. BlossomHill Therapeutics is a ...
According to MarketsandMarkets™, the Sepsis Diagnostics Market is projected to reach USD 1.22 billion by 2031 from USD 0.83 ...
Whole Exome+ Sequencing integrates exome, mitochondrial, and digital karyotype analysis, aiming to reduce standalone CMA ...
According to MarketsandMarkets, the Sepsis Diagnostics Market is projected to reach USD 1.22 billion by 2031 from USD 0.83 billion in 2026, at a ...
The global in vitro diagnostics market is projected to grow from USD 117.39 billion in 2026 to USD 170.10 billion by 2031, registering a CAGR of 7.7% ...
Genomics adoption, rising biopharma R&D and demand for advanced instruments are creating opportunities in sequencing, cell analysis, consumables and services.Dublin, Sept. 15, 2026 (GLOBE NEWSWIRE) -- ...
This is a valuable study that contributes to our understanding of transcriptomic responses in microglia to HIV infection in the human brain. The evidence provided remains incomplete, and further ...
Opportunities center on AI-driven design, high-throughput screening, bioinformatics, RNA therapies, nanotechnology, pharmacogenomics and integrated R&D platforms.Dublin, Sept. 14, 2026 (GLOBE NEWSWIRE ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results